首页 | 本学科首页   官方微博 | 高级检索  
检索        

人巨细胞病毒感染的药物防治进展
引用本文:胡建华,马伟杭.人巨细胞病毒感染的药物防治进展[J].国际流行病学传染病学杂志,2002,36(1):196-199.
作者姓名:胡建华  马伟杭
作者单位:浙江大学医学院附属第一医院传染病研究所,传染病诊治国家重点实验室,杭州,310003;
基金项目:国家重点基础研究发展规划(973计划)国家自然科学基金
摘    要:人巨细胞病毒(HCMV)在人群中感染很普遍,常呈隐性或潜伏感染,但在人体免疫力低下或缺损时,可引起严重的HCNV病.随着抗HCMV药物的广泛应用,HCNV感染的防治取得了较大的进展,但耐药病毒株的不断出现也为HCMV感染的防治带来了新的挑战.此文对常用的抗HCMV药物作一介绍,并对耐药的问题及研发中的药物进行综述.

关 键 词:巨细胞病毒    抗病毒    耐药    预防    治疗    

Progress in anfiviral prevention and treatment of hmnan cytomegalovirus infection
HU Jian-hua,MA Wei-hang.Progress in anfiviral prevention and treatment of hmnan cytomegalovirus infection[J].International Journal of Epidemiology and Infectious Disease,2002,36(1):196-199.
Authors:HU Jian-hua  MA Wei-hang
Abstract:Human cytomegalovirus is one of the most common pathogens among population, and usually causes subclinical or latent infection in immunocompetent persons, but in immunocompromised patients, it can cause severe HCMV disease. The widespread use of the potent antiviral agents has improved considerably the prevention and treatment of human cytomegalovirus infection. Meanwhile, the increasing emergence of the drug-resistant virus strains has brought new challenges. In this article, the common use of anti-HCMV drugs are introduced, and the drug resistances and new drugs under research are reviewed.
Keywords:CytomegalovirnsAntiviralDrug resistancePreventionTreatment
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号